 |
Quitting
smoking and diabetes risk |
| |
The advice of the researchers seems sensible,
that smokers who quit should receive advice about avoiding weight
gain, about diabetes prevention and how to spot the early signs
of the diseas (NHS Choices) |
| |
|
 |
Pedometer
could cut Type 2 diabetes risk by half |
| |
Using a pedometer as part of a structured education
programme could reduce the chances of Type 2 diabetes by more than
50 per cent in those at risk of developing the condition (Diabetes
UK) |
| |
|
 |
Neonatal
hypoglycemia |
| |
The quantitative definition of hypoglycemia
in the newborn remains elusive because it is a surrogate marker
for central nervous system energy deficiency. Nonetheless, the
recognition that hyperinsulinemic hypoglycemia, which produces
profound central nervous system energy deficiency, is most likely
to lead to long-term central nervous system damage, has altered
management of children with hypoglycemia (Current Opinion in Endocrinology,
Diabetes and Obesity) |
| |
|
 |
Update
in neonatal diabetes |
| |
We still have much to learn about the different
forms of neonatal diabetes, their associated clinical features,
and the optimization of therapy using a growing number of available
therapeutic agent (Current Opinion in Endocrinology, Diabetes and
Obesity) |
| |
|
 |
Childhood
Predictors of Adult Type 2 Diabetes at 9- and 26-Year Follow-ups |
| |
Office-based childhood measures predict the
presence and absence of future T2DM 9 and 26 years after baseline.
Childhood insulin measurement improves prediction, facilitating
approaches to primary prevention of T2DM (Archives of Pediatrics & Adolescent Medicine) |
| |
|
 |
Diabetic
Peripheral Neuropathy: Painful or Painless |
| |
Although often overlooked or forgotten, diabetic
peripheral neuropathy (DPN) is common and a frequent cause of morbidity
and disability (Hospital Physician) |
| |
|
 |
Effects
of sitagliptin or metformin added to pioglitazone monotherapy
in poorly controlled type 2 diabetes mellitus patients |
| |
The addition of both sitagliptin or metformin
to pioglitazone gave an improvement of HbA1c, FPG, and PPG; but
metformin led also to a decrease of body weight and to a faster
and better improvement of insulin resistance and inflammatory state
parameters, even if sitagliptin produced a better protection of ß-cell function (Metabolism, Clinical and Experimental) |
| |
|
 |
A1C
Blood Test OK for Diabetes Diagnosis |
| |
New Guidelines Call for Using A1C Blood Test
to Identify People With Prediabetes (WebMD) |
| |
|
 |
Do
people with diabetes understand their clinical marker of long-term
glycemic control (HbA1c levels) and does this predict diabetes
self-care behaviours and HbA1c? |
| |
The majority of participants seemed to have
a poor understanding of HbA1c and this was related to aspects of
their diabetes management, self-efficacy and HbA1c levels (Patient
Education and Counseling) |
| |
|
 |
Optical
Coherence Tomography for Age-Related Macular Degeneration and
Diabetic Macular Edema |
| |
An Evidence-Based Analysis. 22-page PDF (Ministry
of Health and Long-Term Care, Ontario, Canada) |
| |
|
 |
Research
suggests mild cognitive impairment with diabetes increases risk
of progression to dementia |
| |
Older people with memory loss are three times
more likely to develop dementia if they also have diabetes (Institute
of Psychiatry, King’s College London ) |
| |
|
 |
Dr.
Reddy's and Rheoscience Announce Headline Results from First
Phase III Clinical Trial of Balaglitazone |
| |
All three active arms (Balaglitazone 10mg, 20mg
and Pioglitazone 45mg) showed similar levels of efficacy with respect
to both HbA1c and fasting plasma glucose (RTT News) |
| |
|
 |
MannKind
Expects FDA to Approve Inhaled Insulin |
| |
MannKind Corp.’s
President and Chief Operating Officer Hakan Edstrom said he expects
U.S. regulators to approve the company’s experimental inhaled insulin drug by Jan. 16, challenging analysts who predicted
a delay. (BusinessWeek) |
| |
|
 |
Blood
sugar and cancer risk |
| |
Overall, this research provides some evidence
that high blood glucose is associated with an increased risk of
some types of cancer. However, it did not directly test or suggest
that high blood sugar causes these cancers (NHS Choices) |
| |
|